<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04335708</url>
  </required_header>
  <id_info>
    <org_study_id>AHM 001</org_study_id>
    <nct_id>NCT04335708</nct_id>
  </id_info>
  <brief_title>Effect of Intracellular Content From Lactobacillus Casei CRL-431 on Antioxidant Capacity of Breast Milk</brief_title>
  <official_title>Effect of the Administration of the Intracellular Content Obtained From Lactobacillus Casei CRL-431 on the Antioxidant Capacity of Breast Milk</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centro de Investigación en Alimentación y Desarrollo A.C.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centro de Investigación en Alimentación y Desarrollo A.C.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the present study was to evaluate the effect of the consumption of the
      intracellular content of Lactobacillus casei CRL-431 on the antioxidant capacity of breast
      milk
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A double blind randomized controlled clinical study of an 30-d intervention with 16 nursing
      mothers was carried out to evaluate the effect of the consumption of the intracellular
      content of Lactobacillus casei CRL-431 on the antioxidant capacity of breast milk. Once
      obtained the informed consent; volunteers were ramdomized into two groups (n=8) to either
      receive 5 mL daily: edible gel with intracellular content of Lb. casei CRL-431 (intervention
      group) or edible gel without intracellular content of Lb. casei CRL-431 as control (placebo).
      Both gels were consumed daily. Participants were asked not to change their diet or lifestyle
      during the intervention. We applied intention to treat for those participants who did not
      have good adherence and those who withdraw the study. The outcomes between groups were
      analyzed using a independent samples student t-test, with P value of 0.05 or less (two sided)
      when there was a statistical differences. Non-parametric data were analyzed with Mann-Whitney
      test; using statistical software.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2018</start_date>
  <completion_date type="Actual">April 30, 2019</completion_date>
  <primary_completion_date type="Actual">April 30, 2019</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Antioxidant activity oxygen radical absorption capacity</measure>
    <time_frame>Change from baseline antioxidant activity oxygen radical absorption capacity at day 15</time_frame>
    <description>Determination of antioxidant activity by oxygen radical absorption capacity technique in breast milk</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Trolox equivalent Antioxidant capacity</measure>
    <time_frame>Change from baseline Trolox equivalent antioxidant capacity at day 15</time_frame>
    <description>Determination of Trolox equivalent antioxidant capacity in breast milk</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Antioxidant activity oxygen radical absorption capacity</measure>
    <time_frame>Change from baseline antioxidant activity oxygen radical absorption capacity at day 30</time_frame>
    <description>Antioxidant activity by oxygen radical absorption capacity technique in breast milk</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Trolox equivalent antioxidant capacity</measure>
    <time_frame>Change from baseline Trolox equivalent antioxidant capacity at day 30</time_frame>
    <description>Determination of Trolox equivalent antioxidant capacity in breast milk</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Superoxide dismutase enzyme activity</measure>
    <time_frame>Change from baseline superoxide dismutase enzyme activity at day 15</time_frame>
    <description>Determination of dismutase enzyme activity in breast milk</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glutation peroxidase enzyme activity</measure>
    <time_frame>Change from baseline glutation peroxidase enzyme activity at day 15</time_frame>
    <description>Determination of glutation peroxidase enzyme activity in breast milk</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Catalase enzyme activity</measure>
    <time_frame>Change from baseline catalase enzyme activity at day 15</time_frame>
    <description>Determination of catalase enzyme activity in breast milk</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glutathione activity</measure>
    <time_frame>Change from baseline glutathione activity at day 15</time_frame>
    <description>Determination of glutathione activity in breast milk</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vitamin C</measure>
    <time_frame>Change from baseline Vitamin C at day 15</time_frame>
    <description>Determination of Vitamin C in breast milk</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Malondialdehyde</measure>
    <time_frame>Change from baseline malondialdehyde at day 15</time_frame>
    <description>Determination of malondialdehyde products by the thiobarbituric acid reactive substances test in breast milk</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hydrogen peroxide</measure>
    <time_frame>Change from baseline hydrogen peroxide at day 15</time_frame>
    <description>Determination of hydrogen peroxide in breast milk</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxidative stress index</measure>
    <time_frame>Change from baseline oxidative stress index at day 15</time_frame>
    <description>Determination of oxidative stress index in breast milk</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Superoxide dismutase enzyme activity</measure>
    <time_frame>Change from baseline superoxide dismutase enzyme activity at day 30</time_frame>
    <description>Determination of dismutase enzyme activity in breast milk</description>
  </other_outcome>
  <other_outcome>
    <measure>Glutation peroxidase enzyme activity</measure>
    <time_frame>Change from baseline glutton peroxidase enzyme activity at day 30</time_frame>
    <description>Determination of glutation peroxidase enzyme activity in breast milk</description>
  </other_outcome>
  <other_outcome>
    <measure>Catalase enzyme activity</measure>
    <time_frame>Change from baseline catalase enzyme activity at day 30</time_frame>
    <description>Determination of catalase enzyme activity in breast milk</description>
  </other_outcome>
  <other_outcome>
    <measure>Glutathione activity</measure>
    <time_frame>Change from baseline Glutathione activity at day 30</time_frame>
    <description>Determination of glutathione activity in breast milk</description>
  </other_outcome>
  <other_outcome>
    <measure>Vitamin C</measure>
    <time_frame>Change from baseline Vitamin C at day 30</time_frame>
    <description>Determination of Vitamin C in breast milk</description>
  </other_outcome>
  <other_outcome>
    <measure>Malondialdehyde</measure>
    <time_frame>Change from baseline malondialdehyde at day 30</time_frame>
    <description>Determination of malondialdehyde in breast milk</description>
  </other_outcome>
  <other_outcome>
    <measure>Hydrogen peroxide</measure>
    <time_frame>Change from baseline superoxide dismutase enzyme activity at day 30</time_frame>
    <description>Determination of hydrogen peroxide in breast milk</description>
  </other_outcome>
  <other_outcome>
    <measure>Oxidative stress index</measure>
    <time_frame>Change from baseline oxidative stress index at day 30</time_frame>
    <description>Determination of oxidative stress index in breast milk</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Mothers</condition>
  <condition>Lactation</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Daily consumption of 5 mL of edible gel with intracellular content of Lactobacillus casei CRL-431 during 30-d</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Daily consumption of 5 mL of edible gel without intracellular content of Lactobacillus casei CRL-431 during 30-d</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Postibiotic formulation</intervention_name>
    <description>5 mL daily of edible gel with intracellular content of Lactobacillus casei CRL-431</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo formulation</intervention_name>
    <description>5 mL daily of edible gel without intracellular content of Lactobacillus casei CRL-431</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Nursing mothers between 3 and 52 weeks of lactation

        Exclusion Criteria:

          -  Clinical evidence of chronic disease or gastrointestinal disorders

          -  Structural defects in the breast (breast surgery, mammary gland hypoplasia, among
             others)

          -  Mastitis

          -  Cancer and/or radiotherapy

          -  Consumption of: antioxidant supplements, probiotics, symbiotics and/or antibiotics in
             the month prior to recruitment.

          -  Alcohol or drugs consumption
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adrian Hernández-Mendoza, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CENTRO DE INVESTIGACION EN ALIMENTACION Y DESARROLLO, A.C.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centro de Investigacion En Alimentacion Y Desarrollo, A.C.</name>
      <address>
        <city>Hermosillo</city>
        <state>Sonora</state>
        <zip>83304</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>March 17, 2020</study_first_submitted>
  <study_first_submitted_qc>April 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 6, 2020</study_first_posted>
  <last_update_submitted>April 3, 2020</last_update_submitted>
  <last_update_submitted_qc>April 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centro de Investigación en Alimentación y Desarrollo A.C.</investigator_affiliation>
    <investigator_full_name>Adrian Hernandez Mendoza</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Nursing mothers</keyword>
  <keyword>Breast milk</keyword>
  <keyword>Lactobacillus</keyword>
  <keyword>intracellular content</keyword>
  <keyword>antioxidant capacity</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

